Cargando…
Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells
Tumour progression is regulated by the balance of proliferation and apoptosis in the tumour cell population. To date, the role of vascular endothelial growth factor (VEGF) in tumour growth has been attributed to the induction of angiogenesis. VEGF has been shown to be a survival factor for endotheli...
Autores principales: | Pidgeon, G P, Barr, M P, Harmey, J H, Foley, D A, Bouchier-Hayes, D J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364032/ https://www.ncbi.nlm.nih.gov/pubmed/11461089 http://dx.doi.org/10.1054/bjoc.2001.1876 |
Ejemplares similares
-
The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease
por: Pidgeon, G P, et al.
Publicado: (1999) -
A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells
por: Barr, M P, et al.
Publicado: (2005) -
Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat
por: Xie, B, et al.
Publicado: (1999) -
Bcl-w expression in colorectal adenocarcinoma
por: Wilson, J W, et al.
Publicado: (2000) -
Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix
por: Loncaster, J A, et al.
Publicado: (2000)